2012
DOI: 10.1038/jp.2012.54
|View full text |Cite
|
Sign up to set email alerts
|

Predicting preterm birth: where do the major challenges lie?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2017
2017

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 8 publications
(7 reference statements)
0
1
0
Order By: Relevance
“…After injection, glucocorticoid bioactivity in the fetus lasts for several days ( 9 ) and can exert long-lasting effects upon the hypothalamic–pituitary–adrenal (HPA) axis and cognition in children ( 10 , 11 ). Of note, 30–80% of women with symptoms of preterm birth have not delivered 14 days later ( 12 ), and more than half of the women who received ACS delivered later than one week after treatment or after 34 weeks of gestation ( 13 ), among them one third after gestation week 37 ( 14 ). Especially this population of neonates is likely to encounter more harm than benefits from the prenatal treatment with glucocorticoids.…”
Section: Introductionmentioning
confidence: 99%
“…After injection, glucocorticoid bioactivity in the fetus lasts for several days ( 9 ) and can exert long-lasting effects upon the hypothalamic–pituitary–adrenal (HPA) axis and cognition in children ( 10 , 11 ). Of note, 30–80% of women with symptoms of preterm birth have not delivered 14 days later ( 12 ), and more than half of the women who received ACS delivered later than one week after treatment or after 34 weeks of gestation ( 13 ), among them one third after gestation week 37 ( 14 ). Especially this population of neonates is likely to encounter more harm than benefits from the prenatal treatment with glucocorticoids.…”
Section: Introductionmentioning
confidence: 99%